M. Stek

发表

Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry

M. Shivaprakash, C. Viscoli, J. Maertens, 2010, BMC infectious diseases.

Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.

E. Timmermans, P. Reiss, F. Wit, 2005, The Journal of infectious diseases.

Dose‐Finding Study of a Once‐Daily Indinavir/Ritonavir Regimen

P. Reiss, J. Lange, J. Lange, 2000, Journal of acquired immune deficiency syndromes.

Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96‐week outcomes of HIV‐NAT 009

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2005, HIV medicine.

REACTIVITY OF ANTI-MSA1 MONOCLONAL ANTIBODY WITH SCHISTOSOMAL AND NON-SCHISTOSOMAL ANTIGENIC EXTRACTS

M. Stek, R. Pelley, F. Boctor, 1983, The Lancet.

CHANGING PATTERN OF SCHISTOSOMIASIS IN EGYPT

M. Stek, 1979, The Lancet.

Simplification and standardization of dot-ELISA for human schistosomiasis mansoni.

J. Peter, M. Stek, F. Boctor, 1987, The Journal of parasitology.

Pharmacokinetic Interaction Study of Indinavir/Ritonavir and the Enteric‐Coated Capsule Formulation of Didanosine in Healthy Volunteers

P. Reiss, R. Aarnoutse, Y. Hekster, 2005, Journal of clinical pharmacology.

Boosted versus Unboosted Indinavir with Zidovudine and Lamivudine in Nucleoside Pre-Treated Patients: A Randomized, Open-Label Trial with 112 Weeks of Follow-Up (HIV-Nat 005)

K. Ruxrungtham, D. Cooper, P. Reiss, 2006, Antiviral therapy.

Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients.

K. Ruxrungtham, D. Cooper, P. Reiss, 2003, The Journal of antimicrobial chemotherapy.

Experience of Healthcare Workers Taking Postexposure Prophylaxis After Occupational HIV Exposures: Findings of the HIV Postexposure Prophylaxis Registry

A. Panlilio, A. Saah, S. Wang, 2000, Infection Control & Hospital Epidemiology.

The influence of efavirenz on the pharmacokinetics of a twice‐daily combination of indinavir and low‐dose ritonavir in healthy Volunteers

P. Reiss, R. Aarnoutse, D. Burger, 2002, Clinical pharmacology and therapeutics.

Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir

K. Ruxrungtham, D. Cooper, J. Miners, 2006, Pharmacogenetics and genomics.

Pharmacokinetics of Indinavir/Ritonavir (800/100 mg) in Combination With Efavirenz (600 mg) in HIV‐1‐Infected Subjects

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2003, Journal of acquired immune deficiency syndromes.

Treatment of bilharzial colonic polyposis with praziquantel.

N. El-Masry, Z. Farid, M. Stek, 1985, The Journal of infectious diseases.

Bacteriuria and hematuria in infections due to Schistosoma haematobium.

O. Kassim, M. Stek, 1983, The Journal of infectious diseases.

DEVELOPMENT OF CIRCULATING ANTIGEN ASSAY FOR RAPID DETECTION OF ACUTE SCHISTOSOMIASIS

M. Stek, K. Hunter, E. Hayunga, 1986, The Lancet.

Murine immunization by cesium-137 irradiation attenuated Schistosoma mansoni cercariae.

M. Stek, D. Cruess, P. Minard, 1984, The Journal of parasitology.

Early diagnosis of Schistosoma mansoni in mice using assays directed against cercarial antigens isolated by hydrophobic chromatography.

M. Stek, K. Hunter, E. Hayunga, 1987, The Journal of parasitology.

Erythroadsorption and enzyme-linked immunoassays (EAIA and ELISA) for specific circulating antibodies and antigens in schistosomiasis.

M. Stek, 1984, Annales d'immunologie.

Purification of the Major Concanavalin A-Binding Surface Glycoprotein from Adult Schistosoma mansoni

M. Stek, W. Vannier, E. Hayunga, 2012 .

Circumoval precipitin (COP) test in schistosomiasis with frozen Schistosoma mansoni eggs.

M. Stek, S. A. Ismail, J. Leef, 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

A Once-Daily Haart Regimen Containing Indinavir + Ritonavir plus One Or Two Nucleoside Reverse Transcriptase Inhibitors (Pipo Study)

J. Dieleman, I. Gyssens, J. Nouwen, 2002, Antiviral therapy.

Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load

D. Podzamczer, J. Gatell, P. Reiss, 2003, AIDS.

Hospital pharmacists and infectious diseases specialists

G. Eliopoulos, D. Sexton, F. Tenover, 1997 .

Praziquantel for treatment of schistosomiasis in patients with advanced hepatosplenomegaly.

N. El-Masry, Z. Farid, M. Stek, 1985, Annals of tropical medicine and parasitology.

Precision and Discriminatory Ability of Calcaneal Bone Assessment Technologies

E. Orwoll, S. Greenspan, K. Faulkner, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.